Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease

Volume 306:1513-1519		June 24, 1982		Number 25

Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease

RA Norum, JB Lakier, S Goldstein, A Angel, RB Goldberg, WD Block, DK Noffze, PJ Dolphin, J Edelglass, DD Bogorad, and P Alaupovic

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

Abstract

We studied two sisters 29 and 31 years old who had skin and tendon xanthomas, corneal clouding, and severe coronary atherosclerosis. Histologic examination showed collections of lipid-laden histiocytes in the skin. The patients' plasma cholesterol concentrations were 177 and 135 mg per deciliter (4.58 and 3.49 mmol per liter). Levels of high-density-lipoprotein cholesterol were 4 and 7 mg per deciliter (0.1 and 0.2 mmol per liter). Only traces of apolipoprotein A-I were detected in whole plasma. The plasma density fraction from 1.06 to 1.21 g per milliliter contained no high-density lipoprotein on high-pressure liquid chromatography, no apolipoprotein A-I on sodium dodecyl sulfate electrophoresis, and only traces of apolipoprotein A-I on radioimmunoassay. Apolipoprotein C-III was also not detectable. The activity of lecithin-cholesterol acyltransferase was 40 per cent of normal. The half-life of infused normal high-density lipoprotein was three days (normal, 5.8 days). The parents and children of these two patients had low levels of high-density-lipoprotein cholesterol and apolipoprotein A-I. These cases support the hypothesis that low concentrations of high-density lipoprotein promote atherosclerosis.

This article has been cited by other articles:

Santos, R. D., Schaefer, E. J., Asztalos, B. F., Polisecki, E., Wang, J., Hegele, R. A., Martinez, L. R. C., Miname, M. H., Rochitte, C. E., Da Luz, P. L., Maranhao, R. C. (2008). Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency. J. Lipid Res. 49: 349-357 [Abstract] [Full Text]
Gomaraschi, M., Baldassarre, D., Amato, M., Eligini, S., Conca, P., Sirtori, C. R., Franceschini, G., Calabresi, L. (2007). Normal Vascular Function Despite Low Levels of High-Density Lipoprotein Cholesterol in Carriers of the Apolipoprotein A-IMilano Mutant. Circulation 116: 2165-2172 [Abstract] [Full Text]
Gorgels, T. G.M.F., Hu, X., Scheffer, G. L., van der Wal, A. C., Toonstra, J., de Jong, P. T.V.M., van Kuppevelt, T. H., Levelt, C. N., de Wolf, A., Loves, W. J.P., Scheper, R. J., Peek, R., Bergen, A. A.B. (2005). Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 14: 1763-1773 [Abstract] [Full Text]
Fagan, A. M., Christopher, E., Taylor, J. W., Parsadanian, M., Spinner, M., Watson, M., Fryer, J. D., Wahrle, S., Bales, K. R., Paul, S. M., Holtzman, D. M. (2004). ApoAI Deficiency Results in Marked Reductions in Plasma Cholesterol But No Alterations in Amyloid-{beta} Pathology in a Mouse Model of Alzheimer's Disease-Like Cerebral Amyloidosis. Am. J. Pathol. 165: 1413-1422 [Abstract] [Full Text]
Moore, R. E., Kawashiri, M.-a., Kitajima, K., Secreto, A., Millar, J. S., Pratico, D., Rader, D. J. (2003). Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor. Arterioscler. Thromb. Vasc. Bio. 23: 1914-1920 [Abstract] [Full Text]
Brown, B. G., Cheung, M. C., Lee, A. C., Zhao, X.-Q., Chait, A. (2002). Antioxidant Vitamins and Lipid Therapy: End of a Long Romance?. Arterioscler. Thromb. Vasc. Bio. 22: 1535-1546 [Abstract] [Full Text]
Indolfi, C. (2002). Genetic factors in atherosclerosis: status and perspectives. Eur Heart J Suppl 4: B14-B16 [Abstract]
Sorci-Thomas, M. G., Thomas, M., Curtiss, L., Landrum, M. (2000). Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice. J. Biol. Chem. 275: 12156-12163 [Abstract] [Full Text]
Jong, M. C., Hofker, M. H., Havekes, L. M. (1999). Role of ApoCs in Lipoprotein Metabolism : Functional Differences Between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Bio. 19: 472-484 [Full Text]
Huang, W., Sasaki, J., Matsunaga, A., Nanimatsu, H., Moriyama, K., Han, H., Kugi, M., Koga, T., Yamaguchi, K., Arakawa, K. (1998). A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency. Arterioscler. Thromb. Vasc. Bio. 18: 389-396 [Abstract] [Full Text]
Moriyama, K., Sasaki, J., Takada, Y., Matsunaga, A., Fukui, J., Albers, J. J., Arakawa, K. (1996). A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency. Arterioscler. Thromb. Vasc. Bio. 16: 1416-1423 [Abstract] [Full Text]
Nanjee, M.N., Crouse, J.R., King, J.M., Hovorka, R., Rees, S.E., Carson, E.R., Morgenthaler, J.-J., Lerch, P., Miller, N.E. (1996). Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans. Arterioscler. Thromb. Vasc. Bio. 16: 1203-1214 [Abstract] [Full Text]
Ng, D. S., Vezina, C., Wolever, T. S., Kuksis, A., Hegele, R. A., Connelly, P. W. (1995). Apolipoprotein A-I Deficiency : Biochemical and Metabolic Characteristics. Arterioscler. Thromb. Vasc. Bio. 15: 2157-2164 [Abstract] [Full Text]
Takata, K., Saku, K., Ohta, T., Takata, M., Bai, H., Jimi, S., Liu, R., Sato, H., Kajiyama, G., Arakawa, K. (1995). A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease. Arterioscler. Thromb. Vasc. Bio. 15: 1866-1874 [Abstract] [Full Text]
Tilly-Kiesi, M., Qiuping, Z., Ehnholm, S., Kahri, J., Lahdenpera, S., Ehnholm, C., Taskinen, M.-R. (1995). ApoA-IHelsinki (Lys107->0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency. Arterioscler. Thromb. Vasc. Bio. 15: 1294-1306 [Abstract] [Full Text]
Marcil, M., Boucher, B., Krimbou, L., Solymoss, B. C., Davignon, J., Frohlich, J., Genest, J. Jr (1995). Severe Familial HDL Deficiency in French-Canadian Kindreds : Clinical, Biochemical, and Molecular Characterization. Arterioscler. Thromb. Vasc. Bio. 15: 1015-1024 [Abstract] [Full Text]
Ikewaki, K., Zech, L. A., Kindt, M., Brewer, H. B. Jr, Rader, D. J. (1995). Apolipoprotein A-II Production Rate Is a Major Factor Regulating the Distribution of Apolipoprotein A-I Among HDL Subclasses LpA-I and LpA-I:A-II in Normolipidemic Humans. Arterioscler. Thromb. Vasc. Bio. 15: 306-312 [Abstract] [Full Text]
Ito, Y, Azrolan, N, O'Connell, A, Walsh, A, Breslow, J. (1990). Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249: 790-793 [Abstract]
Prioli, R., Ordovas, J., Rosenberg, I, Schaefer, E., Pereira, M. (1987). Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein. Science 238: 1417-1419 [Abstract]
Lambert, G., Sakai, N., Vaisman, B. L., Neufeld, E. B., Marteyn, B., Chan, C.-C., Paigen, B., Lupia, E., Thomas, A., Striker, L. J., Blanchette-Mackie, J., Csako, G., Brady, J. N., Costello, R., Striker, G. E., Remaley, A. T., Brewer, H. B. Jr., Santamarina-Fojo, S. (2001). Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice. J. Biol. Chem. 276: 15090-15098 [Abstract] [Full Text]

Comments and questions? Please contact us.